
This study examines the use of process capability index results to establish sampling strategies for new product cleaning and to minimize the risk of insufficient cleaning.
Kosuke Takenaka is principal scientist of Biologics & New Modalities Development; Pharmaceutical Sciences at Takeda Pharmaceutical Company Limited.

This study examines the use of process capability index results to establish sampling strategies for new product cleaning and to minimize the risk of insufficient cleaning.

The approach presented in this study uses process capability index results to establish sampling strategies for use with new product cleaning and to efficiently reduce the risk of insufficient cleaning.

Published: May 2nd 2018 | Updated:

Published: June 7th 2018 | Updated: